Delbridge, Alex R. D.
Grabow, Stephanie
Strasser, Andreas
Vaux, David L.
Article History
First Online: 29 January 2016
Competing interests
: A.R.D.D., S.G., A.S. and D.L.V. are employed by the Walter and Eliza Hall Institute. The Walter and Eliza Hall Institute receives milestone payments from Genentech Inc. and AbbVie for the development of BH3-mimetic drugs ABT-199 and ABT-263 for cancer therapy.